John Brancaccio - Mar 9, 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ John Brancaccio
Stock symbol
CRDF
Transactions as of
Mar 9, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 05:38 PM
Previous filing
Dec 3, 2021
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +26.8K +27.2% $0.00 125K Mar 9, 2022 Common Stock 26.8K $2.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.